tamibarotene has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clemente, D; de Castro, F; Melero-Jerez, C; Moliné-Velázquez, V; Ortega, MC; Vila del Sol, V | 1 |
1 other study(ies) available for tamibarotene and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Topics: Animals; Apoptosis; Benzoates; Cell Differentiation; Cell Survival; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Immune Tolerance; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Relapsing-Remitting; Myeloid Progenitor Cells; Neutrophils; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Spinal Cord; T-Lymphocytes; Tetrahydronaphthalenes | 2014 |